Grand Research Store

Irritable Bowel Syndrome Treatment Market Industry Growth by 2018

Press Release   •   Apr 12, 2018 13:11 IST

This report studies the Irritable Bowel Syndrome Treatment market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Irritable Bowel Syndrome Treatment market by product type and application/end industries.

Prescription drug market for IBS was valued at $1.6 billion across the 7MM in 2016, and GlobalData expects it to increase to $2.6 billion in 2026, at a compound annual growth rate (CAGR) of 4.8% from 2016–2026. The US contributed over 90% of the market share in 2016, which is linked to the large IBS population and high prescription drug prices in this market compared with the 5EU and Japan.

Three pipeline therapies are expected to launch during the forecast period, which will contribute to the US IBS market growth (CAGR of 5.1% from 2016–2026). Japan will have the slowest market growth (at a CAGR of 0.2%), with the 5EU showing the solid growth (at a CAGR of 4.5%), despite the fact that no therapies are expected to launch in Europe during the forecast
Despite the projected growth of the IBS marketplace, all of the currently marketed therapies are anticipated to lose patent protection during the forecast period, which GlobalData anticipates to shift market dynamics towards the use of generic versions of these therapies due to their significantly lower cost. In addition, many patients with IBS manage their symptoms using over-the-counter (OTC) products, which are beyond the scope for this report but nonetheless mitigate the current and future uptake of prescription drugs indicated for IBS

Download FREE Sample of this Report @ https://www.24marketreports.com/report-sample/20182025-irritable-bowel-syndrome-treatmenton-market-45

The AsiaPacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Irritable Bowel Syndrome Treatment.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share % and growth Rate % of Irritable Bowel Syndrome Treatment in these regions, from 2013 to 2025 forecast, covering

  • United States
  • North America
  • Europe
  • AsiaPacific
  • South America
  • Middle East and Africa

The major players in global and United States market, including

  • Abbott Laboratories
  • Synergy Pharmaceuticals, Inc.
  • Sucampo Pharmaceuticals, Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Novartis AG
  • GlaxoSmithKline plc.
  • Ironwood Pharmaceuticals, Inc.

On the basis of product, the market is primarily split into

  • Lubiprostone
  • Linaclotide
  • Eluxadoline
  • Rifaximin
  • Ramosetron Hydrochloride
  • Others

On the basis on the end users/application, this report covers

  • Hospital
  • Clinic
  • Home Care

Get the Complete Report & TOC @ https://www.24marketreports.com/life-sciences/20182025-irritable-bowel-syndrome-treatmenton-market-45

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Table of content

20182025 Irritable Bowel Syndrome Treatment Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer

2 Irritable Bowel Syndrome Treatment Market Overview
2.1 Irritable Bowel Syndrome Treatment Product Overview
2.2 Irritable Bowel Syndrome Treatment Market Segment by Type
2.2.1 Lubiprostone
2.2.2 Linaclotide
2.2.3 Eluxadoline
2.2.4 Rifaximin
2.2.5 Ramosetron Hydrochloride
2.2.6 Others
2.3 Global Irritable Bowel Syndrome Treatment Product Segment by Type
2.3.1 Global Irritable Bowel Syndrome Treatment Sales K Pcs and Growth % by Type 2013, 2017 and 2025
2.3.2 Global Irritable Bowel Syndrome Treatment Sales K Pcs and Market Share % by Type 20132018
2.3.3 Global Irritable Bowel Syndrome Treatment Revenue Million USD and Market Share % by Type 20132018
2.3.4 Global Irritable Bowel Syndrome Treatment Price USD/Pcs by Type 20132018
2.4 United States Irritable Bowel Syndrome Treatment Product Segment by Type
2.4.1 United States Irritable Bowel Syndrome Treatment Sales K Pcs and Growth by Type 2013, 2017 and 2025

If You Have Any Question Related To This Report Contact Us @ https://www.24marketreports.com/enquire-now/20182025-irritable-bowel-syndrome-treatmenton-market-45

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Fax: (+1) 212 634 4885
Email: help@24marketreports.com

Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports

24Market Reports is a well-known market research reports company, currently serving a huge database of more than 1 million market reports and 50k company profiles worldwide. We provide our users with most authentic and accurate market research reports across various verticals.